Alzheimer's Assocation Research only
All of alz.org
  • Go to Alz.org
  • Research Center
  • AAIC
  • ISTAART
  • Journal
  • Grants
  • TrialMatch
  • Press
  • Donate
  • Contact Us
Home
Science and Progress
Clinical Trials
Funding and Collaboration
You can Help
Stay Current
Video and Resources

Text Size

Small text Medium text Large text

Types of Research Grants


Grants Overview Types of Grants Process and Timeline Funded Studies

The Alzheimer's Association funds a wide variety of investigations by scientists at every stage of their careers. Each grant is designed to meet the needs of the field and to introduce fresh ideas in Alzheimer's research.


Alzheimer's Innovation Award (AIA)

The prevention of Alzheimer's disease is a bold aspiration; the U.S. National Plan to Address Alzheimer's disease sets the goal to effectively treat and prevent Alzheimer's by 2025. The Alzheimer's Association and Johnson & Johnson Innovation share this vision and have joined together to offer a unique opportunity to advance projects that are directed at translating their findings towards the development of innovative new therapeutic agents and advancing efforts to address the global crisis of Alzheimer's Disease. Massachusetts, Connecticut and Rhode Island have a uniquely dynamic, entrepreneurial and creative science and technology heritage, with an emphasis on the creation, commercialization and sustainment of disruptive technologies and solutions from its medical science-based companies and leading research institutes and universities.

The Alzheimer's Innovation Award (AIA) will work with research teams in the Massachusetts, Connecticut and Rhode Island to seek out cutting edge research directed towards the development of new therapeutic small molecules that can progress to the clinical treatment of Alzheimer's disease and related dementias.

Both non-profit and small for-profit agencies from Massachusetts, Connecticut and Rhode Island are eligible. Small for-profit organizations with <=$2MM investments (i.e. exclusion of for-profit entities with a >$2MM series A) and must provide documentation verifying status.

Letters of Intent (LOI) must be received by 5:00 PM EST, June 25, 2018. All LOIs must be submitted online at https://proposalcentral.altum.com. No hard copies or emails will be accepted.

For those invited to submit a full proposal, applications must be received by 5:00 PM EST, August 10, 2018.



GAAIN Exploration to Evaluate Novel Alzheimer's Queries (GEENA-Q)

Program Goal:
The GAAIN Exploration to Evaluate Novel Alzheimer's Queries (GEENA-Q) will stimulate researchers to interrogate the federated GAAIN network for new discoveries in Alzheimer's research.

Background:
The Global Alzheimer's Association Interactive Network (GAAIN) is a big data platform for cohort discovery and data exploration focused on Alzheimer's disease and dementia. GAAIN provides tools that allow researchers to explore diverse clinical, health factor, genetic, and imaging datasets from Data Partners around the world quickly and intuitively. GAAIN currently has nearly 500,000 unique clinical records from nearly 30 clinical studies around the world available for interrogation across data elements.

The GAAIN Interrogator provides an analytical platform from which to explore, query, and visualize GAAIN data. One key new feature is the capacity to conduct preliminary analyses on remotely accessible data. The new tool is highly flexible and enables users to easily create custom cohorts to use in analyses.

Program Description:
The GEENA-Q program will support scientific investigation using the GAAIN tools to generate creative insights into Alzheimer's and dementia queries. Projects will be awarded $25,000 to launch and carry forward discovery based research to address targeted questions. GEENA-Q aims to accelerate our knowledge of biological and/or clinical change across the continuum of disease.

Applications to the GEENA-Q program will be accepted that utilize the GAAIN platform to explore novel questions in Alzheimer's and dementia research. Proposals should focus on correlations and investigations across multiple data sets, and utilize the GAAIN Data Partners for the specific area of interest. Proposals should clearly outline the type of study, the rationale for the query, the plan to further advance the investigation.

Eligibility:
Applications are encouraged from research laboratories and teams around the world. Researchers with full-time staff or faculty appointments are encouraged to apply. Post-doctoral fellows are eligible to apply as a principal investigator (PI), but must collaborate with an administrative PI who serves as the director of the laboratory in which the research will be conducted. The administrative PI will be responsible for assisting in providing all institutional documents required for the project and will be required to sign any award contract. Training or mentoring-only proposals will not be considered.

Letters of Intent (LOI) must be received by 5:00 PM ET, April 4, 2018.

For more information regarding GEENA-Q: Contact grantsapp@alz.org or call 1.312.335-5747 or 1.312.335.5862.

For more information regarding GAAIN: Visit GAAIN.org or email info@gaain.org.

 



2018 International Research Grant Program - June Program (February - August 2018)


Alzheimer's Association Research Grant (AARG)

The Alzheimer's Association Research Grant aims to fund investigators who are less than 10 years past their doctoral or post residency (MD or DO). The purpose of this program is to provide newly independent investigators with funding that will allow them to develop preliminary or pilot data, to test procedures and to develop hypotheses. The Alzheimer's Association recognizes the need to increase the number of scientists from underrepresented groups in the research enterprise. Young scientists from these groups are encouraged to apply. Applicants must be Assistant Professors or above at their respective institution.



Alzheimer's Association Research Grant to Promote Diversity (AARG-D)

The Alzheimer's Association Research Grant to Promote Diversity program award is up to three years (minimum 2 years) to increase the number of scientist from underrepresented groups at academic institutions in Alzheimer's or related dementias research. The AARG-D aims to fund investigators who are less than 10 years past their doctoral or post residency (MD or DO). The objective of this award is to increase the number of highly trained investigators from diverse backgrounds whose basic, clinical and social/behavioral research interests are grounded in the advanced methods and experimental approaches needed to solve problems related to Alzheimer's and related dementias in general and in health disparities populations. The Alzheimer's Association recognizes the need to increase the number of scientist from underrepresented groups participating in biomedical and behavioral research. The Association anticipates that by providing these research opportunities, the number of scientist from underrepresented groups entering and remaining in biomedical research careers in Alzheimer's disease will increase.



Alzheimer's Association Research Grant — New to the Field (AARG-NTF)

The Alzheimer's Association Research Grant — New to the Field (AARG-NTF) aims to fund investigators who are over the 10 years since last terminal degree and are new to Alzheimer's and related dementia field of research. Individuals who are over 10 years since last terminal degree and new to the field of neuroscience or neurodegeneration (Alzheimer's, Parkinson's, Lewy body dementia, etc) will be considered for this program. If you are still within 10 years since last terminal degree you must apply to the regular AARG program.



Alzheimer's Association Research Grant to Promote Diversity — New to the Field (AARG-D-NTF)

The Alzheimer's Association Research Grant to Promote Diversity- New to the Field program award is up to three years (minimum 2 years) to increase the number of scientist from underrepresented groups at academic institutions in Alzheimer's or related dementias research. The AARG-D-NTF aims to fund individuals over the 10 years since last terminal degree and are new to Alzheimer's and related dementia field of research. Individuals who are over 10 years since last terminal degree and new to the field of neuroscience or neurodegeneration (Alzheimer's, Parkinson's, Lewy body dementia, etc) will be considered for this program. If you are still within 10 years since last terminal degree you must apply to the regular AARG program.



Alzheimer's Association Research Fellowship (AARF)

The Alzheimer's Association Research Fellowship Award Program is a three year (minimum 2 year) award intended to support exceptional researchers who are engaged in their post-graduate work (i.e. postdoctoral fellows) and before they have their first independent faculty positions (i.e. Assistant Professor) with the goal of bridging the fellow to faculty positions of researchers. Please note, individuals applying to the program will be accepted from postdoctoral fellows with full time positions at their respective institution who have less than 10 years of research experience after receipt of their doctorate or other terminal degree. Individuals who have a position of an Assistant Professorship or above are not eligible.



Alzheimer's Association Research Fellowship to Promote Diversity (AARF-D)

The Alzheimer's Association Research Fellowship Award to Promote Diversity Program is a three year (minimum 2 year) award intended to support exceptional researchers who are currently underrepresented at academic institutions in Alzheimer's or related dementias research and who are engaged in their post-graduate work (i.e. postdoctoral fellows) and before they have their first independent faculty positions (i.e. Assistant Professor) with the goal of bridging fellow to faculty position of researchers. Please note, individuals applying to the program will be accepted from postdoctoral fellows with full time positions at their respective institution who have less than 10 years of research experience after receipt of their doctorate or other terminal degree. Individuals who have a position of an Assistant Professorship or above are not eligible.



Alzheimer's Association Clinician Scientist Fellowship (AACSF)

The Alzheimer's Association recognizes the need to support the training of clinician scientists in Alzheimer's and related dementias. For the purpose of this program, a clinician scientist is defined as an individual already trained, licensed and practicing in a clinical field that includes patient contact (e.g., neurology, psychiatry, geriatrics, psychology) or patient-related diagnostic studies (e.g.,neuropathology and radiology). Applicants who hold an M.D. or D.O. degree or applicants with a Ph.D. who have licensure for clinical practice are eligible. Please note, individuals applying to the program will be accepted from individuals with full time positions at their respective institution who are within 10 years of receiving their M.D., D.O. or Ph.D. (or equivalent), including postdoctoral fellows through Assistant Professors. Positions higher than Assistant Professor will not be considered.

Please note individuals must be currently in a clinical setting.



Alzheimer's Association Clinician Scientist Fellowship to Promote Diversity (AACSF-D)

The Alzheimer's Association Clinician Scientist Fellowship to Promote Diversity is up to three years (minimum 2 years) and is intended to support exceptional clinician scientist who are currently underrepresented at academic institutions in clinical research training in Alzheimer's and related dementias. Applicants who hold an M.D. or D.O. degree or applicants with a Ph.D. who have licensure for clinical practice are eligible. For the purpose of this fellowship, clinical research is defined as patient-oriented research conducted with human subjects, or translational research specifically designed to develop treatments or enhance diagnosis of neurological disease. These areas of research include epidemiologic or behavioral studies, clinical trials, studies of disease mechanisms, the development of new technologies, and health services and outcomes research." Disease related studies not directly involving humans or human tissue are also encouraged if the primary goal is the development of therapies, diagnostic tests, or other tools to prevent or mitigate neurological diseases. The Alzheimer's Association recognizes the need to increase the number of underrepresented clinicians participating in clinical research. The Association anticipates that by providing this funding opportunity, the number of underrepresented physicians entering and remaining in clinical careers in Alzheimer's disease will increase. Please note, individuals applying to the program will be accepted from individuals with full time positions at their respective institution who are within 10 years of receiving their M.D., D.O. or Ph.D. (or equivalent), including postdoctoral fellows through Assistant Professors. Positions higher than Assistant Professor will not be considered.

Please note individuals must be currently in a clinical setting.



The Zenith Fellows Award Program (Zenith)

The Zenith Fellows award was initiated in 1991 to provide a vehicle for research support for donors with a substantial personal commitment to the advancement of Alzheimer's disease research. The awards are made possible by the generosity of a group of individuals and organizations (Zenith Society) that have each committed $1 million to the Alzheimer's Association for support of the program.

The objective of the 2018 Zenith Fellows Awards competition is to provide major support for investigators who have:

  • Contributed significantly to the field of Alzheimer's disease research,
  • Made significant contributions to other areas of science and are now beginning to focus more directly on problems related to Alzheimer's disease, and
  • Are likely to make substantial contributions in the future.

The proposed research must be "on the cutting edge" of basic science or biomedical research and thus may not conform to current conventional scientific wisdom or may challenge the prevailing orthodoxy. The proposed research should address fundamental problems related to early detection, etiology, pathogenesis, treatment and/or prevention of Alzheimer's disease.



CLOSED: The PART THE CLOUD to RESCUE (REverse, reStore, Cease and UndErstand) Brain Cell Degeneration in Alzheimer's disease

 



CLOSED: The Tau Pipeline Enabling Program (T-PEP)

Full program details can be found at alz.org/T-PEP.




By Invitation for Atlantic Fellows Only

CLOSED: Pilot Awards for Global Brain Health Leaders

 


 

 

 

For more information: Contact grantsapp@alz.org or call 312.335.5747.